We are live on ! Find out more
HEC

Hudson Executive Capital Portfolio holdings

AUM $151M
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
+0.88%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$1.04B
AUM Growth
-$39.4M
Cap. Flow
+$8.9M
Cap. Flow %
0.86%
Top 10 Hldgs %
99.46%
Holding
11
New
2
Increased
1
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
SMG icon
ScottsMiracle-Gro
SMG
+$32M
2
CTLP
Cantaloupe
CTLP
+$26.3M
3
NTRA icon
Natera
NTRA
+$8.35M

Top Sells

Rank Stock Value
1
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$8.3M
2
ATRC icon
AtriCure
ATRC
+$7.6M

Sector Composition

Rank Sector Weight
1 Financials 48.17%
2 Industrials 21.39%
3 Healthcare 9.98%
4 Technology 5.15%
5 Materials 3.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DB icon
1
Deutsche Bank
DB
$68.1B
$500M 48.17%
64,861,476
– –
CATM
2
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$222M 21.39%
8,126,933
– –
SPY icon
3
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$787B
$58.3M 5.62%
199,000
-145,500
-42% -$41.9M
CTLP
4
DELISTED
Cantaloupe
CTLP
$53.5M 5.15%
7,195,720
+4,246,880
+144% +$26.3M
EGRX
5
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$45.2M 4.35%
811,777
-159,223
-16% -$8.3M
CVRS
6
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$42.4M 4.09%
14,235,545
– –
IWM icon
7
PUT
iShares Russell 2000 ETF
IWM
$81.6B
$35.6M 3.43%
229,000
– –
SMG icon
8
ScottsMiracle-Gro
SMG
$4B
$35.5M 3.42%
+360,275
New +$32M
STOR
9
DELISTED
STORE Capital Corporation
STOR
$29.6M 2.85%
890,800
– –
NTRA icon
10
Natera
NTRA
$37.8B
$10.4M 1.01%
+378,589
New +$8.35M
ATRC icon
11
AtriCure
ATRC
$1.7B
$5.6M 0.54%
187,678
-260,300
-58% -$7.6M

Similar funds

SHF
Stage Harbor Financial Westwood, Massachusetts $151M AUM 15.9% 1-Year Est. Return
FWM
Fingerlakes Wealth Management Ithaca, New York $151M AUM 20.78% 1-Year Est. Return
CCM
Crew Capital Management Cincinnati, Ohio $151M AUM 20.49% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BDS
Banco de Sabadell Miami, Florida $151M AUM 22.94% 1-Year Est. Return
MWA
Merkkuri Wealth Advisors Hicksville, New York $151M AUM 14.38% 1-Year Est. Return
WBCM
Wilson & Boucher Capital Management Moraga, California $151M AUM 18.75% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return

Hudson Executive Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Hudson Executive Capital held 11 positions worth $1.04B, down 3.7% from $1.08B the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Hudson Executive Capital's Q2 2019 filing shows 2 new, 1 increased and 3 reduced positions. Its largest new stake was ScottsMiracle-Gro: 360,275 shares worth $35.5M. The largest sale was Eagle Pharmaceuticals, Inc., an estimated $8.3M.

By sector, the portfolio is most concentrated in Financials at 48% of assets, down from 49% a quarter earlier, followed by Industrials and Healthcare.

  • Hudson Executive Capital's largest Q2 2019 buy was ScottsMiracle-Gro: 360,275 shares worth $35.5M.
  • Hudson Executive Capital added most to Cantaloupe in Q2 2019, an estimated $26.3M increase.
  • Hudson Executive Capital's biggest Q2 2019 reduction was Eagle Pharmaceuticals, Inc., cutting an estimated $8.3M.
  • Hudson Executive Capital's ten largest holdings make up 99% of its $1.04B portfolio in Q2 2019.
  • Hudson Executive Capital opened 2 new positions and closed 0 in Q2 2019.
  • Hudson Executive Capital's portfolio value fell 3.7% quarter-over-quarter to $1.04B.

Based on Hudson Executive Capital's 13F filing for Q2 2019, filed 14 Aug 2019.